000 | 01346 a2200349 4500 | ||
---|---|---|---|
005 | 20250513164105.0 | ||
264 | 0 | _c19990429 | |
008 | 199904s 0 0 eng d | ||
022 | _a0264-410X | ||
024 | 7 |
_a10.1016/s0264-410x(98)00154-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHopkins, W J | |
245 | 0 | 0 |
_aAssociation of human leucocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection. _h[electronic resource] |
260 |
_bVaccine _cJan 1999 |
||
300 |
_a169-71 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aBacterial Infections _xgenetics |
650 | 0 | 4 |
_aBacterial Vaccines _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHLA Antigens _xgenetics |
650 | 0 | 4 |
_aHLA-DR2 Antigen _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunity, Mucosal _xgenetics |
650 | 0 | 4 | _aImmunogenetics |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aUrinary Tract Infections _xgenetics |
650 | 0 | 4 |
_aVagina _ximmunology |
700 | 1 | _aHeisey, D M | |
700 | 1 | _aUehling, D T | |
773 | 0 |
_tVaccine _gvol. 17 _gno. 2 _gp. 169-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(98)00154-6 _zAvailable from publisher's website |
999 |
_c9948563 _d9948563 |